Investigating how Sirt6 protects against glaucoma
Neuroprotective Role of Sirt6 in Glaucoma
This study is looking at how a protein called Sirt6 might help protect the eyes from damage in people with glaucoma, which can cause vision loss, and aims to find new ways to treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project ID | NIH-10850861 on NIH RePORTER |
What this research studies
This research focuses on understanding the neuroprotective role of Sirt6 in glaucoma, a condition that leads to irreversible blindness due to the death of retinal ganglion cells. The study aims to explore mechanisms beyond intraocular pressure that contribute to glaucoma progression, utilizing advanced genetic models and non-invasive imaging techniques. By examining the functions of Sirt6, which is involved in aging and inflammation, the research seeks to identify new therapeutic targets for glaucoma treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glaucoma, particularly those who have not responded adequately to current treatments.
Not a fit: Patients with glaucoma who have advanced disease and are already experiencing significant vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent or slow down vision loss in glaucoma patients.
How similar studies have performed: While the role of Sirt6 in glaucoma is not well-established, similar approaches targeting neuroprotection in other neurodegenerative diseases have shown promise.
Where this research is happening
Galveston, United States
- University of Texas Med Br Galveston — Galveston, United States (Active)
Researchers
- Principal investigator: Liu, Hua — University of Texas Med Br Galveston
- Study coordinator: Liu, Hua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.